Background Dengue viral infection may cause mild to severe
Dengue virus infections may be subclinical or manifest as dengue fever (DF) or dengue hemorrhagic fever, headache, myalgia, and rash, accompanied by leukopenia and varying degrees of thrombocytopenia. 3 An early clinical diagnosis of DHF is difficult because the World Health Organization (WHO) clinical and laboratory criteria for DHF may be manifested only in the late phase of acute illness. 4 The latest WHO sign of dengue, leading to severe dengue when it presents as severe bleeding.
The pathogenesis of bleeding in dengue viral thrombopathy, and coagulopathy. These 3 mechanisms are caused by interconnected complement activation cascades. [3] [4] [5] Measuring vasculopathy, thrombopathy, and coagulopathy is complex, expensive, and cannot be done in all health care settings. The routine follow-up for dengue patients includes a simple and low-cost complete blood examination, especially in the post-febrile defervesence period, which is a particularly critical phase. The aim of this study was to determine the predictive value of simple laboratory examination on bleeding tendency in dengue patients. The examinations include packed count, all of which are available in limited resource settings.
Methods
This cross-sectional study was undertaken from 
Results
numbers of male and female patients with dengue viral infection were not significantly different. The incidence of petechial bleeding appeared greater than mucosal bleeding in each of the above blood parameter groups. The basic characteristics of subjects are shown Table 2 shows the OR of predicting the risk of for mucosal bleeding than those with platelet count
Discussion
Dengue has a wide spectrum of clinical presentations, often with unpredictable clinical evolution and outcomes. While most patients recover following a self-limiting, non-severe clinical course, a small proportion progress to severe disease, mostly characterized by plasma leakage with or without hemorrhage. 6 groups symptomatic dengue virus infections into three and dengue hemorrhagic fever (DHF). DHF is further classified into four severity grades, with grades III and IV being defined as dengue shock syndrome. There are several difficulties in applying these criteria in that some cases cannot be classified into criteria guideline is more practical for clinicians. The defined as a person who traveled or lived in an endemic for each subject in our calculations in this study with the assumption that patients were in the critical phase at that time. The critical phase is characterized by count. Although a bleeding tendency usually occurs as a manifestation of plasma leakage and shock,it may occur in cases without plasma leakage (previously classified as dengue fever), usually manifested as thrombocytopenia. Among the bleeding cases, was a potential risk factor for mucosal bleeding, only compared to petechial bleeding.
in dengue, which is caused by vascular leakage. One possible cause of vascular leakage is platelet activating such as hypotension, increased vascular permeability, cytokine release, and shock. Thrombocytopenia and plasma leakage are the main characteristics of severe dengue disease. It has been postulated that autoimmunity is involved in dengue pathogenesis, especially through the generation of autoantibodies against platelets, endothelial cells, and coagulatory products. The crossreactive antibodies may cause platelet dysfunction, endothelial cell damage, coagulation defects, and macrophage activation.
The platelets count and the platelets usage for sealing the vascular breakage may be considered as the cause of bleeding. The OR of platelets in non-bleeding and petechial cases (mild bleeding) was only 2.34, petechial and mucosal) than subjects with platelet times greater risk of having petechial bleeding than the notion that petechial bleeding may be considered as a milder and less dangerous bleeding tendency than mucosal bleeding. However, we did not evaluate other parameters to assess bleeding tendency in this study, such as hemostatic states by activated partial (mucosal bleeding). This hemorrhaging may be caused by a thrombopathy (platelet dysfunction), in addition to the decrease of platelets in peripheral blood. Thus, the decrease in platelets count (thrombocytopenia) may not be the only cause of bleeding, but may be one risk factor for bleeding tendency during dengue infection.
involves the role of both vascular endothelial cells and platelets, although the pathogenic mechanism such as CMV, HIV, and hepatitis C virus has shown the presentation of platelet autoantibodies to be the cause of thrombocytopenia. In dengue viral infection these auto anti-platelet antibodies induce complement-mediated cell lysis, which may play role in thrombocytopenia. During blood vessel injury, activated platelets adhere to the injury site, aggregating together through fibrin formation. Carlos et al concluded that thrombocytopenia was not the only cause of bleeding in dengue, but that the concentration were strongly associated with severity of vascular leakage, leading to hypotension, shock and finally bleeding. 3 Other studies have reported that viremia may play a role in determining clinical parameters, as is the case of secondary infection. Higher viral load may be used as an independent predictor for more severe thrombocytopenia, but may also be associated with a small increase in hemoconcentration.
Examinations to determine viral load are expensive and not available in all settings.
The leukocyte count of our subjects was not significantly associated with a bleeding tendency. Hence, it should not be considered as a risk factor for predicting bleeding. However, several studies have reported contrasting result on leukocyte counts in dengue. A Thai study showed that leukopenia was a good predictor of dengue infection in children, whilea study in Nicaragua stated that leukopenia was significantly associated with dengue in adults, but not about the role of leukopenia in dengue, but their results showed that leukocyte counts in dengue cases cases.
was a significant risk factor for shock in dengue. However, the authors did not mention an association between leukopenia and hemorrhage. petechial or mucosal. Furthermore, a platelet count risk for mucosal bleeding. Leukocyte count was notsignificantly correlated to bleeding in our dengue cases. As such, a basic laboratory examination of of bleeding in pediatric dengue cases. 
